Evidence map›Paper›PMID 20082212›Full record

ArticleJournal of bioenergetics and biomembranes2010

The effect of NBD-Cl in nucleotide-binding of the major subunit alpha and B of the motor proteins F1FO ATP synthase and A1AO ATP synthase.

Cornelia Hunke, Vikeramjeet Singh Tadwal, Malathy Sony Subramanian Manimekalai, Manfred Roessle, Gerhard Grüber

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of bioenergetics and biomembranes, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cornelia HunkeSchool of Biological Sciences, Nanyang Technological University, Singapore, 637551, Republic of Singapore.
Vikeramjeet Singh Tadwal
Malathy Sony Subramanian Manimekalai
Manfred Roessle
Gerhard Grüber

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subunit alpha of the Escherichia coli F(1)F(O) ATP synthase has been produced, and its low-resolution structure has been determined. The monodispersity of alpha allowed the studies of nucleotide-binding and inhibitory effect of 4-Chloro-7-nitrobenzofurazan (NBD-Cl) to ATP/ADP-binding. Binding constants (K ( d )) of 1.6 microM of bound MgATP-ATTO-647N and 2.9 microM of MgADP-ATTO-647N have been determined from fluorescence correlation spectroscopy data. A concentration of 51 microM and 55 microM of NBD-Cl dropped the MgATP-ATTO-647N and MgADP-ATTO-647N binding capacity to 50% (IC(50)), respectively. In contrast, no effect was observed in the presence of N,N'-dicyclohexylcarbodiimide. As subunit alpha is the homologue of subunit B of the A(1)A(O) ATP synthase, the interaction of NBD-Cl with B of the A-ATP synthase from Methanosarcina mazei Gö1 has also been shown. The data reveal a reduction of nucleotide-binding of B due to NBD-Cl, resulting in IC(50) values of 41 microM and 42 microM for MgATP-ATTO-647N and MgADP-ATTO-647N, respectively.

Indexed as

4-Chloro-7-nitrobenzofurazanAdenosine DiphosphateAdenosine TriphosphateArchaeal ProteinsBacterial Proton-Translocating ATPasesBase SequenceDNA PrimersEnzyme InhibitorsEscherichia coliEscherichia coli ProteinsKineticsModels, MolecularMolecular Motor ProteinsProtein SubunitsProton-Translocating ATPasesScattering, Small Angle4-Chloro-7-nitrobenzofurazanA1A0 ATPase, Methanosarcina mazeiAdenosine DiphosphateAdenosine TriphosphateArchaeal ProteinsatpB protein, E coliBacterial Proton-Translocating ATPasesDNA PrimersEnzyme InhibitorsEscherichia coli ProteinsMolecular Motor ProteinsProtein SubunitsProton-Translocating ATPases

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.